Disclosure of financial conflicts of interest: cui bono, cui malo?
نویسندگان
چکیده
منابع مشابه
Cui bono robo sapiens?
Ever since Czech writer Karel Capek's well-known play " R.U.R. – Rossum's universal robots " [Capek], first published in 1920 and performed in 1921, man-made robots of human-like shape have inspired fiction writers to envision worlds with artificial creatures far superior to human beings – either in friendly coexistence or taking over by eliminating their creators and leaving them behind as an ...
متن کاملThe Perioperative Surgical Home: Cui Bono?
In recentyears,attentionhasbeendirected to theconcept of the Perioperative Surgical Home (PSH). The origin of this concept can be attributed to the introductionof ambulatory surgery and the riseofpreadmission testing centers, which led to improvements in the preoperative recognition and management of risk factors and a reduction in the use of preoperative screening services and tests that provi...
متن کاملThe demise of professional courtesies: cui bono?
The past is another country: they do things differently there. Hartley LP. The go-between 1 ne indulgence accorded to those of us in our senior years is the ability to reflect on life' s circumstances many decades ago and compare them with those of today. My recollections of medical practice, as the son of a surgeon, stretch back to my schooldays. A lasting memory is of the many gifts, the so-c...
متن کاملTargeting Bcl-2 in CLL: cui bono?
ing this work to humans. First, we do not know whether the molar concentration of CD3 is similarly limiting for the expression of transgenic human TCRs. If CD3 is indeed limiting, then the enhanced expression and functionality we achieve by cotransfection of CD3 and TCRs may be accompanied by enhanced toxicity. Thus, enhanced expression may increase the risk of mispairing of endogenous and tran...
متن کاملMetformin and cancer: Quo vadis et cui bono?
How many lives have already been saved by the anti-cancer drug metformin? Inadvertently perhaps, among the millions of type 2 diabetics with occult or known cancers and who have been prescribed metformin since the 1950s, thousands may have benefited from the anticancer properties of this first-line pharmacotherapy. Quo vadis? Now, researchers aim to move metformin from a non-targeted stage of c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Royal Society of Medicine
سال: 2014
ISSN: 0141-0768,1758-1095
DOI: 10.1177/0141076814542915